You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 14, 2025

Details for New Drug Application (NDA): 077421

✉ Email this page to a colleague

« Back to Dashboard

NDA 077421 describes LORATADINE, which is a drug marketed by Aurobindo Pharma, Bionpharma, Catalent Pharma, Marksans Pharma, Onesource Specialty, Sun Pharma Canada, Aurobindo Pharma Ltd, Hetero Labs Ltd Iii, Lannett Co Inc, Perrigo, Pharm Assoc, Ranbaxy Labs Ltd, Taro, Teva, Wockhardt Bio Ag, Perrigo Pharma Intl, Sun Pharm, Actavis Labs Fl Inc, Glaxosmithkline, Rubicon Research, Tenshi, Adaptis, Anda Repository, Apotex, Granules, Hetero Labs Ltd V, Mylan, Pharmobedient, Pld Acquisitions Llc, Sun Pharm Inds Ltd, Unique Pharm, Heritage Pharma, and P And L, and is included in forty-six NDAs. It is available from one hundred and fifty-two suppliers. Additional details are available on the LORATADINE profile page.

The generic ingredient in LORATADINE is loratadine; pseudoephedrine sulfate. There are thirty-nine drug master file entries for this compound. Thirty-one suppliers are listed for this compound. Additional details are available on the loratadine; pseudoephedrine sulfate profile page.

Summary for 077421

Tradename:	LORATADINE
Applicant:	Lannett Co Inc
Ingredient:	loratadine
Patents:	0

Medical Subject Heading (MeSH) Categories for 077421

Anti-Allergic Agents
Antipruritics
Histamine H1 Antagonists, Non-Sedating

Suppliers and Packaging for NDA: 077421

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
LORATADINE	loratadine	SYRUP;ORAL	077421	ANDA	ATLANTIC BIOLOGICALS CORP.	17856-0557	17856-0557-1	72 CUP, UNIT-DOSE in 1 BOX, UNIT-DOSE (17856-0557-1) / 5 mL in 1 CUP, UNIT-DOSE (17856-0557-2)
LORATADINE	loratadine	SYRUP;ORAL	077421	ANDA	A-S Medication Solutions	50090-1454	50090-1454-0	120 mL in 1 CARTON (50090-1454-0)

Profile for product number 001

Active Rx/OTC/Discontinued:	OTC	Dosage:	SYRUP;ORAL			Strength	1MG/ML
Approval Date:	Jun 29, 2006	TE:		RLD:	No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.